Back
KraneShares Emerging Markets Consumer Tech Idx ETF Vs. Krystal Biotech, Inc. Industry Stock Comparison
Buy
65
KEMQ
KraneShares Emerging Markets Consumer Tech Idx ETF
Last Price:
$25.70
Seasonality Move:
0.75%
Buy
75
KRYS
Krystal Biotech, Inc.
Last Price:
$240.89
Seasonality Move:
5.72%
Buy
65
KraneShares Emerging Markets Consumer Tech Idx ETF (KEMQ)
is a Buy
Is KraneShares Emerging Markets Consumer Tech Idx ETF a Buy, Sell or Hold?
-
The current KraneShares Emerging Markets Consumer Tech Idx ETF [KEMQ] share price is $25.66. The Score for KEMQ is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
KEMQ is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Krystal Biotech, Inc. (KRYS)
is a Buy
Is Krystal Biotech, Inc. a Buy, Sell or Hold?
-
The current Krystal Biotech, Inc. [KRYS] share price is $240.80. The Score for KRYS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
KRYS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KEMQ Stock Price Chart
What is KraneShares Emerging Markets Consumer Tech Idx ETF's stock price today?
-
The KraneShares Emerging Markets Consumer Tech Idx ETF share price today is $25.66Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KEMQ is experiencing selling pressure, which indicates risk of future bearish movement.
KRYS Stock Price Chart
What is Krystal Biotech, Inc.'s stock price today?
-
The Krystal Biotech, Inc. share price today is $240.80Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KRYS is experiencing slight buying pressure.
KEMQ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 49.19 | Sell |
| Chaikin Money Flow: | -2297 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.25 - 26.01) | Buy |
| Bollinger Bands (100): | (23.83 - 26.77) | Buy |
KRYS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.84 | Buy |
| Relative Strength Index (14 RSI): | 68.35 | Buy |
| Chaikin Money Flow: | 226476 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (210.18 - 238.06) | Buy |
| Bollinger Bands (100): | (150.15 - 213.59) | Buy |
KEMQ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.46 | Buy |
| 20-day SMA: | 25.58 | Buy |
| 50-day SMA: | 26.05 | Sell |
| 200-day SMA: | 22.79 | Buy |
| 8-day EMA: | 25.43 | Buy |
| 20-day EMA: | 25.63 | Buy |
| 50-day EMA: | 25.35 | Buy |
| 200-day EMA: | 16.23 | Buy |
KRYS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 240.33 | Buy |
| 20-day SMA: | 228.78 | Buy |
| 50-day SMA: | 208.63 | Buy |
| 200-day SMA: | 167.73 | Buy |
| 8-day EMA: | 237.28 | Buy |
| 20-day EMA: | 229.15 | Buy |
| 50-day EMA: | 210.93 | Buy |
| 200-day EMA: | 178.26 | Buy |
KraneShares Emerging Markets Consumer Tech Idx ETF Earnings Growth & KEMQ Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Krystal Biotech, Inc. Earnings Growth & KRYS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.37 per share, and an increase next year of $1.76 per share.
KraneShares Emerging Markets Consumer Tech Idx ETF Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Krystal Biotech, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||